Lipton joins the Second Kukulcan Corps. He longs to ride the Kukulcan in the sky with his fellow Kukulcan airmen, while unifying with these other soldiers in slightly lecherous behavior during this youthful story. And while the Kukulcan Corps are an all-male society, Lipton learns that the soldier he bunks with, Tsubasa Chino, is actually a woman? This flying fantasy love comedy could actually become a romance manga!

Nature-centered economics for the age of peak oil

A dazzling look at Mayan mythology incarnate from New York Times bestselling author Steve Alten.

An account of the decade-long conflict between humankind and hordes of the predatory undead is told from the perspective of dozens of survivors who describe in their own words the epic human battle for survival, in a novel that is the basis for the June 2013 film starring Brad Pitt. Reissue. Movie Tie-In.

Since the introduction of recombinant human growth hormone and insulin a quarter century ago, protein therapeutics has greatly broadened the ho- zon of health care. Many patients suffering with life-threatening diseases or chronic dysfunctions, which were medically untreatable not long ago, can attest to the wonder these drugs have achieved. Although the ?rst generation of p- tein therapeutics was produced in recombinant Escherichia coli, most recent products use mammalian cells as production hosts. Not long after the ?rst p- duction of recombinant proteins in E. coli, it was realized that the complex tasks of most post-translational modi?cations on proteins could only be ef?ciently carried out in mammalian cells. In the 1990s, we witnessed a rapid expansion of mammalian-cell-derived protein therapeutics, chie?y antibodies. In fact, it has been nearly a decade since the market value of mammalian-cell-derived protein therapeutics surpassed that of those produced from E. coli. A common characteristic of recent antibody products is the relatively large dose required for effective therapy, demanding larger quantities for the treatment of a given disease. This, coupled with the broadening repertoire of protein drugs, has rapidly expanded the quantity needed for clinical applications. The increasing demand for protein therapeutics has not been met exclusively by construction of new manufacturing plants and increasing total volume capacity. More - portantly the productivity of cell culture processes has been driven upward by an order of magnitude in the past decade.

The first in a four-volume set, The Cambridge World History of Violence, Volume 1 provides a comprehensive examination of violence in prehistory and the ancient world. Covering the Palaeolithic through to the end of classical antiquity, the chapters take a global perspective spanning sub-Saharan Africa, the Near East, Europe, India, China, Japan and Central America. Unlike many previous works, this book does not focus only on warfare but examines violence as a broader phenomenon. The historical approach complements, and in some cases critiques, previous research on the anthropology and psychology of violence in the human story. Written by a team of contributors who are experts in each of their respective fields, Volume 1 will be of particular interest to anyone fascinated by archaeology and the ancient world.